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ABSTRACT
Human (h) DNA repair enzyme thymine DNA
glycosylase (hTDG) is a key DNA glycosylase in the
base excision repair (BER) pathway that repairs
deaminated cytosines and 5-methyl-cytosines. The
cell cycle checkpoint protein Rad9–Rad1–Hus1
(the 9-1-1 complex) is the surveillance machinery
involved in the preservation of genome stability. In
this study, we show that hTDG interacts with hRad9,
hRad1 and hHus1 as individual proteins and as a
complex. The hHus1 interacting domain is mapped
to residues 67–110 of hTDG, and Val74 of hTDG
plays an important role in the TDG–Hus1 interaction.
In contrast to the core domain of hTDG (residues
110–308), hTDG(67–308) removes U and T from U/G
and T/G mispairs, respectively, with similar rates as
native hTDG. Human TDG activity is significantly
stimulated by hHus1, hRad1, hRad9 separately,
and by the 9-1-1 complex. Interestingly, the inter-
action between hRad9 and hTDG, as detected by
co-immunoprecipitation (Co-IP), is enhanced follow-
ing N-methyl-N’-nitro-N-nitrosoguanidine (MNNG)
treatment. A significant fraction of the hTDG
nuclear foci co-localize with hRad9 foci in cells
treated with methylating agents. Thus, the 9-1-1
complex at the lesion sites serves as both a
damage sensor to activate checkpoint control and
a component of the BER.
INTRODUCTION
The base excision repair (BER) pathway recognizes a large
variety of spontaneous and induced DNA lesions (1–3).
The ﬁrst step of BER is carried out by a lesion-speciﬁc
DNA glycosylase. These enzymes ﬁnd lesions in the vast
genomic DNA and excise the damaged bases to generate
potentially mutagenic apurinic/apyrimidinic (AP) sites
using a base-ﬂipping mechanism (4). About one-third of
germ-line mutations leading to genetic disease are at CpG
sites (5), which are susceptible to spontaneous deamina-
tion yielding U/G and T/G mismatches. Several DNA
glycosylases are involved in the repair of U/G mismatches.
In addition to U/G mismatches, thymine DNA glycosy-
lase (TDG) and methyl-binding domain IV (MBD4/
Med1) recognize and initiate the repair of T/G mismatches
and other toxic and mutagenic lesions. TDG belongs to
a large glycosylase family that can excise uracil
from DNA including MUG, UNG and SMUG1. The
mechanism of substrate recognition of TDG (6,7) is
distinguished from other DNA glycosylases in two
respects. (i) TDG recognizes a wide array of DNA lesions
including U/G, T/G, 3,N
4-ethenocytosine (eC)/G, and
T/O
6-methylguanine (MeG) mispairs as well as several
oxidized bases such as thymine glycol, 5-formyl-U,
5-hydroxy-U and 5-hydroxy-methyl-U (8–10). (ii) TDG
removes U or T from U/G or T/G mismatches,
respectively, only on double-stranded DNA, and with
signiﬁcant speciﬁcity for CpG sites (7,11).
The catalytic domain of human (h) TDG resides within
residues 123–300 (9,12). The ﬂexible N-terminal domain
accounts for the nonspeciﬁc DNA binding and slows its
dissociation from AP site (13). Human hTDG can be
modiﬁed by the small ubiquitin-like modiﬁer (SUMO)
proteins at Lys-330, which aﬀects its dissociation from
DNA and its interaction with apurinic/apyrimidinic
endonuclease (APE1) (13,14). The structure of hTDG
(residues 112–339) conjugated to SUMO-1 is very similar
to Escherichia coli mismatch DNA glycosylase (MUG)
(15,16). TDG has been shown to interact with, and
modulate the activity of, proteins involved in transcrip-
tional regulation (17). These interacting proteins include
the retinoic acid and retinoid X receptors (18), the
estrogen receptor (19), the transcription factor c-Jun
(19,20), the thyroid transcription factor-1 (21) and the
CBP/p300 transcriptional co-activators (17). CBP/p300
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residues 70, 94, 95 and 98, which suppresses the
stimulation of TDG by APE1 (17). Moreover, TDG
interacts with nucleotide excision repair XPC–RAD23B
protein complex, which enhances TDG turnover (22).
Because Tdg
 /  knockout mice are embryonically lethal
(23), TDG must play an essential role during develop-
ment. So far, TDG is the only glycosylase that is essential
for mouse development. This indicates that other DNA
glycosylases such as MBD4 and UNG2 cannot substitute
TDGs function even if they have some overlapping
substrate speciﬁcities.
DNA repair is coordinated with cell cycle progression
and DNA-damage checkpoints (3,24). Cell cycle check-
points are surveillance mechanisms that monitor the cell’s
state, preserve genome integrity and play roles in
preventing carcinogenesis (25–28). The signal transduction
pathways triggered by DNA damage involve many
components, including sensors, transducers and eﬀectors.
Human ATM (ataxia telangiectasia mutated) and ATR
(ATM- and Rad3-related protein) are phosphoinositol
phosphate 3 (PI-3) kinase-related kinases (27). ATM
becomes activated in response to double-stranded
DNA breaks, while ATR responds to DNA lesions and
DNA replication blockage. After stress, ATM or ATR
transmits the DNA damage signal by phosphorylating
Chk1, Chk2, p53 and other proteins, which in turn
regulate the cell cycle, DNA repair and apoptosis. DNA
damage signaling is dependent on Rad9–Rad1–Hus1 and
Rad17 sensors. Rad9, Rad1 and Hus1 form a hetero-
trimeric complex (the 9-1-1 complex) that exhibits
structural similarity with the homotrimeric clamp prolif-
erating cell nuclear antigen (PCNA) (29–31). The 9-1-1
complex is loaded onto DNA by Rad17–RFC (32–34).
The 9-1-1 complex is directly associated with many
DNA repair proteins, including factors involved in the
BER pathway. We have shown that the 9-1-1 complex
physically and functionally interacts with two DNA
glycosylases: the MutY homologs (MYHs) (35,36) and
Nei-like glycosylase 1 (NEIL1) (37). The 9-1-1 complex
has been shown to interact with and stimulate other BER
enzymes including APE1 (38), polymerase b (Polb) (39),
ﬂap endonuclease 1 (FEN1) (40,41) and DNA ligase l
(42,43). In the present report, we demonstrate that hTDG
DNA glycosylase physically and functionally interacts
with Rad9, Rad1 and Hus1 as individual proteins and as a
complex. The interacting site of the 9-1-1 complex is
localized to residues 67–110 of hTDG. Val74 of hTDG
plays an important role in TDG–Hus1 interaction. In
addition, the catalytic rates of hTDG(67–308) with U/G
and T/G mismatches are similar to those of intact hTDG
and are greater than those of the TDG-core containing
residues 111–308. Interestingly, the interaction between
hRad9 and hTDG is enhanced after cells are treated by
methylation agents. The role of hTDG in DNA damage
response may be related to the embryonic lethality
of Tdg
 /  knockout mice (23). Our ﬁndings support
the model that checkpoint proteins require a series of
‘adaptors’ to recognize DNA damage and that the 9-1-1
complex is a component of the BER pathway.
MATERIALS AND METHODS
Human cell culture
Human HeLa S3 cells were purchased from American
Type Cell Culture (ATCC), cultured in modiﬁed
Ham’s F-12 (Mediatech) and supplemented with
10% fetal bovine serum (FBS). At 80% conﬂuence,
cells were treated with 0.4mMo fN-methyl-N0-nitro-
N-nitrosoguanidine (MNNG) for diﬀerent times. Cells
were harvested and washed with PBS. Cell extracts were
prepared as described (44,45). The protein concentration
was determined by Bio-Rad protein assay based on the
Bradford method (Bio-Rad).
Construction of expression plasmids forglutathione-S-
transferase (GST)-fusions andHis-hTDG proteinin E. coli
The plasmid pET28-TDG-FL containing full-length
cDNA encoded residues 1–410 of hTDG inserted into
the NheI/SalI site of pET28c was obtained from Dr Primo
Scha ¨ r, University of Basel, Switzerland. The truncated
hTDG constructs were ampliﬁed by polymerase chain
reaction (PCR) method using template pET28-TDG-FL
and primers listed in Table S1 in the supplementary Data.
The PCR products were digested with NheI and SalI and
ligated into the NheI–SalI-digested pET28c vector (EMD
Biosciences) to yield pET28-TDG plasmids of TDG-
core(111–308), TDG(56–308) and TDG-N(1–124). The
PCR products were digested with BamHI and SalI and
ligated into the BamHI–XhoI-digested pGEX-4T-2 vector
(GE Health) or pET-21a vector (EMD Biosciences) to
yield plasmids pGEX-TDG and pET21-TDG, respec-
tively, of TDG-FL, TDGN(111–410), TDGC1(1–308),
TDGN55(56–410) and TDG(67–308). The sequences of
the cloned genes were conﬁrmed by DNA sequencing.
Construction of V44Aand V74AhTDG mutants
Plasmids pET28-hTDG(V44A) and pET28-hTDG(V74A)
were derived from pET28-TDG-FL by the QuickChange
mutagenesis method as per the manufacturer’s instruc-
tions (Stratagene). The mutagenesis of V44A employed
two complementary oligonucleotides, Chang498 (sense
strand) and Chang499 (antisense strand). The muta-
genesis of V74A employed two complementary
oligonucleotides, Chang510 (sense strand) and Chang511
(antisense strand). Plasmids pGEX-4T-hTDG(V44A) and
pGEX-4T-hTDG(V74A) were generated from pGEX-
4T-hTDG-FL by similar mutagenesis method. The
mutants containing V44A and V74A were ﬁrst screened
by NarI and PstI cleavage, respectively, and then
conﬁrmed by DNA sequencing.
Purification of hTDG and deletion constructs expressed
in E. coli
Rosetta cells (Invitrogen) harboring the expression plas-
mids were cultured in LB broth containing 100mg/ml
of ampicillin at 378C. Protein expression was induced
at A590 of 0.6 by the addition of isopropylthiogalactoside
(IPTG) to a ﬁnal concentration of 0.2mM. The cells
were grown at 208C and then harvested 16h later.
Puriﬁcation of hTDG was performed as previously
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His-tagged hTDG-Full, hTDG(V44A), hTDG(V74A),
hTDG-N and TDG-N55 proteins were puriﬁed
by 1ml Hi-Trap-Q column (GE Health). hTDG-C1,
hTDG-core, hTDG(56–308), hTDG(67–308) and
hTDG-N were puriﬁed by 1ml Hi-Trap-SP column (GE
Health). hTDG-C1 and hTDG(V44A) were further
puriﬁed by 1ml Hi-Trap Heparin column (GE Health).
Purification of hRad9,hRad1, hHus1 and theyeast and
human 9-1-1 complexes
His-tagged hHus1 expressed in E. coli BL21 Star cells
(Stratagene) was puriﬁed by Ni-NTA resin (QIAGEN)
and 1ml Hi-Trap Heparin columns (GE Health) as
described (36). The 9-1-1 complex of Schizosaccharomyces
pombe expressed in E. coli was puriﬁed as described (36).
Human Rad9, Rad1, Hus1 and the 9-1-1 complex were
puriﬁed from Sf9 insect cells (Invitrogen) infected with
baculoviruses as described previously (37).
GST pull-down assay
BL21 Star cells (Stratagene) harboring the GST expres-
sion plasmids were cultured in LB broth containing
100mg/ml of ampicillin. Protein expression was induced
as described above. The cell paste from a 500ml culture
was resuspended in 9ml of buﬀer G (50mM Tris–HCl, pH
7.4, 150mM NaCl and 2mM EDTA) containing 0.5mM
DTT and 0.1mM PMSF and treated with lysozyme
(1mg/ml) for 30min at 48C. After sonication, the solution
was centrifuged at 10 000g for 20min and the supernatant
was saved. The GST-tagged proteins were immobilized on
glutathione-Sepharose 4B (GE Health) as described (45).
GST fusion proteins (500ng) were incubated with puriﬁed
proteins (100ng) in 0.2ml volume of buﬀer G containing
0.1% (v/v) NP40 at 48C with shaking overnight. After
centrifugation at 1000g for 2min, the pellets were washed
ﬁve times with 1ml of buﬀer G containing 0.1% (v/v)
NP40. In the experiments involving the 9-1-1 complex,
NP40 was reduced to 0.02% in the incubation and
washing steps. Bound proteins were eluted by boiling in
SDS loading buﬀer (30mM Tris–HCl, pH 6.8, 5% (v/v)
glycerol, 1% SDS, 0.5mg/ml bromophenol blue and 1%
b-mercapoethanol) and resolved on a 12% SDS–poly-
acrylamide gel. The proteins were subsequently analyzed
by western blot using the corresponding antibodies as
described below.
Co-immunoprecipitation
Cell extracts (1mg) were precleared by adding 30ml
Protein G agarose (Invitrogen) for 2h at 48C. After
centrifugation at 1000g, the supernatant was incubated
with 4 mg of monoclonal anti-Rad9 antibody (Imgenex)
overnight at 48C. Protein G agarose (30ml) was added and
incubated for 4h at 48C. After centrifugation at 1000g,
the supernatant was saved and the pellet was washed. The
pellet fractions were resolved on a 12% SDS–PAGE and
western blot analysis for hTDG was performed.
Westernblotting and antibodies
Proteins were separated on SDS–polyacrylamide gels and
transferred to nitrocellulose membranes. The membranes
were blocked with PBS containing 0.1% Tween-20 and
10% nonfat dry milk, reacted with primary antibodies,
and then incubated with horseradish peroxidase-linked
second antibodies with wash between each step (46).
Western blotting was detected by the enhanced chemilu-
minescence (ECL) analysis system (GE Health) according
to the manufacturer’s protocol. Human TDG monoclonal
antibody was from Serotec. Human TDG polyclonal
antibody was a gift of Dr Primo Scha ¨ r, University of
Basel, Switzerland. Monoclonal antibody of Rad9 was
from Imgenex. His-tag, S-tag and FLAG-tag antibodies
were from BD Bioscience, Santa Cruz Biotechnology and
Sigma, respectively.
Immunofluorescence staining
Human HeLa cells cultured in Lab-Tek chamber slides
(NUNC) overnight were treated with 0.4mM of MNNG
(VWR) or 40mM of temozolomide (TMZ) (a gift from
NCI) for 24h. The cells were ﬁxed with 4% formaldehyde
for 15min at room temperature, and permeabilized at
room temperature in PBS 0.5% Triton X-100 for 10min.
After being blocked in PBS containing 15% FBS for
15min at 378C, the cells were reacted with hTDG
polyclonal antibody and hRad9 monoclonal antibody
(Imgenex) at 378C for 30min. Next, the cells were washed
three times with PBS and incubated with Alexa Fluor 594
goat anti-mouse and Alexa Fluro 488 goat anti-rabbit
antibodies (Invitrogen) at a 1:250 dilution in PBS
for 30min at 378C. The cells were then washed
three times in PBS. Nuclear DNA was counterstained
with 40,60-diamidineno-a-phenylindole (DAPI) (Vector
Laboratories). Images were captured by Nikon E400
ﬂuorescent microscope with an attached CCD camera.
TDG glycosylase activity assay
The DNA substrate of hTDG for gel assay is a 44-mer
duplex containing a T/G mismatch (Table S1 in the
Supplementary Data). The strand containing the mis-
paired T was labeled at the 50 end with [g-
32P]ATP by
polynucleotide kinase, annealed with the other strand, and
then ﬁlled-in with Klenow fragment as described by
Lu et al. (47). The hTDG reaction (10ml) contained
50mM Tris–HCl (pH 8.0), 1mM DTT, 50mg/ml bovine
serum albumin, 1mM EDTA and 1.8 fmol (0.18 nM) of
DNA substrate. hHus1, hRad1, hRad9 or the 9-1-1
complex was added immediately after hTDG and reac-
tions proceeded at 378C for 30min. After adding 1.1 mlo f
1N NaOH and incubating at 908C for 30min, the reaction
samples were supplemented with 5ml of formamide dye
(90% formamide, 10mM EDTA, 0.1% xylene cyanol and
0.1% bromophenol blue) and 7ml of the mixture was
loaded onto a 14% polyacrylamide sequencing gel
containing 7M urea. The gel images were viewed on a
PhosphorImager and quantiﬁed using the ImageQuant
software (GE Health). The area at the product position
in the control lane (no protein) was used to subtract
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calculated by the percentage of product over total DNA
(product plus substrate bands).
Because hTDG is strongly inhibited by its AP DNA
product (7), we used single turnover kinetics and saturat-
ing enzyme conditions to compare the activities of
diﬀerent hTDG constructs under the exact conditions as
described (8). The reaction (550 ml) contained 5mM
hTDG, 20mM HEPES (pH 7.5), 0.2mM EDTA,
2.5mM MgCl2, 0.1M NaCl, 0.1mg/ml bovine serum
albumin and 500 nM of 19-mer DNA substrate containing
a T/G or U/G mismatch (Table S1 in the Supplementary
Data) and proceeded at 228C. Samples (100ml) taken at
speciﬁc time points were quenched with 50ml of quench
solution (0.3M NaOH and 0.03M EDTA), incubated at
858C for 15min, and then analyzed by high-pressure
liquid chromatography (HPLC) to determine the reaction
progress (8). Rate constants were determined by ﬁtting the
data to a single-exponential equation using nonlinear
regression with Graﬁt 5 (48).
RESULTS
The human 9-1-1 complexinteracts withhTDG
We have shown that the 9-1-1 complex physically and
functionally interacts with the human and S. pombe
MYHs (35,36) and NEIL1 (37). Both MYH and NEIL1
glycosylases are involved in repair of oxidized bases. To
determine whether the 9-1-1 complex interacts with other
DNA glycosylases responsible for other types of DNA
damage, we tested hTDG which is involved in repairing
DNA lesions derived from deamination. First, we used the
GST pull-down assay to show the physical interactions of
hTDG with hRad9, hHus1 and hRad1. GST-hHus1,
GST-hRad1 or GST-hRad9 fusion protein bound to
glutathione-Sepharose was incubated with puriﬁed hTDG
protein (residues 1–410). As shown in Figure 1A, hTDG
could be pulled down to a similar extent by GST-hHus1,
GST-hRad1 and GST-hRad9. The individual proteins
used in Figure 1A were expressed separately in E. coli,
thus hTDG can interact with hHus1, hRad1 and hRad9
when they are not in a complex.
To test whether hTDG interacts with the 9-1-1 complex,
GST-hTDG fusion protein was bound to glutathione-
Sepharose and incubated with S. pombe 9-1-1 complex
expressed in E. coli or the human 9-1-1 complex expressed
in the baculovirus system. Figure 1C and D show that all
three subunits of both complexes could be pulled down by
GST-hTDG. The interaction between hTDG and the 9-1-1
complex was also demonstrated by co-immunoprecipita-
tion (Co-IP). We used hRad9 antibody to Co-IP hTDG
from HeLa cell extracts. As shown in Figure 1B (lane 2),
hTDG could be immunoprecipitated by hRad9 antibody.
Mapping the9-1-1 interacting domain within hTDG
By using truncated hTDG proteins, we determined the
region of hTDG engaged in the physical interaction with
the 9-1-1 complex. The results are shown in Figure 2 and
summarized in Figure 3. In Figure 2A and B, GST-hTDG
fusion proteins bound to glutathione-Sepharose were used
to pull down His-tagged hHus1 expressed in E. coli. Both
hTDG-N(111–410) and hTDG-core(111–308) exhibited
no interaction with hHus1 (Figure 2A), however, hTDG-
N(1–124) and hTDG-C1(1–308) could interact with
hHus1 (Figure 2B, lane 3 and data not shown). As shown
in Figure 2C, hTDG-C1 could be pulled down by GST-
hHus1, GST-hRad1 and GST-hRad9 immobilized on
glutathione-Sepharose beads. Thus, the 9-1-1 complex
interacts with hTDG through the N-terminal domain
(residues 1–110). To narrow down the hHus1 interacting
domain on hTDG, we made three additional N-terminal
deletion constructs. hTDG-55 (Figure 2B, lane 2),
hTDG(56–308) (data not shown) and hTDG(67–308)
(Figure 2D, lane 2) could interact with hHus1.
hTDG(67–308) could also interact with hRad1 and
hRad9 (Figure 2D, lanes 3 and 4). Therefore, residues
67–110 of hTDG are essential for the interaction of hTDG
with the 9-1-1 components.
Figure 1. Physical interactions of hTDG with hHus1, hRad1, hRad9
and the 9-1-1 complex. (A) hTDG binds to all subunits of the 9-1-1
complex. GST-hHus1 (lane 2), GST-hRad1 (lane 3), GST-hRad9
(lane 4) and GST alone (lane 5) were immobilized on glutathione-
sepharose and incubated with puriﬁed hTDG-full (100ng). The pellets
were fractionated by a 12% SDS–PAGE followed by western blot
analysis with the hTDG antibody. Lane 1 contains 10ng (10% of the
total input) of hTDG. (B) Co-IP of hTDG by hRad9 antibody
in extracts prepared from HeLa cells following MNNG treatment.
HeLa cells were treated with 0.4mM of MNNG for indicated time.
Immunoprecipitation were performed with antibody against hRad9 in
extracts and the western blot was detected by hTDG polyclonal
antibody (lanes 2–4). Lane 1 is a negative control in which the
immunoprecipitation was performed with antibody against FLAG.
(C) Binding of the Schizosaccharomyces pombe 9-1-1 complex to GST-
hTDG. GST-tagged hTDG (lane 2) or GST beads (lane 3) were
incubated with the puriﬁed S. pombe 9-1-1 complex (100ng) expressed
in E. coli. The SpHus1, SpRad1 and SpRad9 proteins were tagged with
a C-terminal His, N-terminal His and C-terminal S-tag, respectively.
Lane 1 contains 10ng (10% of the total input) of the 9-1-1 complex.
The western blot was detected by a mixture of the antibodies
against His-tag and S-tag. (D) Binding of the human 9-1-1 complex
to GST-hTDG. GST-tagged hTDG (lane 2) or GST beads (lane 3) were
incubated with the puriﬁed human 9-1-1 complex (100ng) expressed in
baculovirus system. The hHus1, hRad1 and hRad9 proteins were
all tagged with FLAG. Lane 1 contains 10ng (10% of the total input)
of the 9-1-1 complex. The western blot was detected by FLAG
antibody.
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hRad9, andthe 9-1-1 complexTDG
Because hTDG physically interacts with hHus1, hRad1
and hRad9 as individual proteins and as a complex, we
tested whether the glycosylase activity of hTDG can be
enhanced by hHus1, hRad1, hRad9 or the 9-1-1 complex.
We used hHus1 and the 9-1-1 complex of S. pombe
expressed in E. coli (36) as well as puriﬁed hHus1, hRad1,
hRad9 and the 9-1-1 complex expressed in the baculo-
virus-transfected insect cells (37). We added increasing
amounts of puriﬁed hHus1, hRad1, hRad9 and the 9-1-1
complex to the hTDG glycosylase reactions with DNA
substrate containing a T/G mismatch. As shown in
Figure 4A (lanes 3–8), the hTDG activity was enhanced
signiﬁcantly by hHus1 protein expressed in bacteria. The
diﬀerence between hTDG (0.1 nM) alone and hTDG with
25 nM of hHus1 was approximately 7-fold (Figure 4D).
Human Hus1 alone at 25 nM did not have glycosylase
activity on the substrate containing a T/G mismatch
(Figure 4A, lane 9). A similar stimulation eﬀect on the
hTDG glycosylase activity was observed separately with
hHus1, hRad1 and hRad9 expressed in the baculovirus
system (Figure 4G and H). The human 9-1-1 complex
expressed in the baculovirus system and the 9-1-1 complex
of S. pombe expressed in E. coli also stimulated the hTDG
activity (Figure 4B, C, E and F). Interestingly, the 9-1-1
complex has a stronger stimulation eﬀect on hTDG
activity than hHus1, hRad1 and hRad9, separately.
Functionalinteractionisparallelwiththephysicalinteraction
between hTDG and hHus1
The above physical interaction results indicate that
the 9-1-1 complex interacts with hTDG through the
N-terminal domain (residues 67–110). hTDG(67–308)
is the smallest construct of hTDG which contains
glycosylase activity and retains interaction with hHus1.
We then test the stimulation eﬀects of hHus1 to
His-tagged hTDG deletion constructs. The activities
of hTDGN55(56–410), hTDGC1(1–308) and
hTDG(67–308) could be enhanced by hHus1 (Figure 5).
However, hHus1 did not enhance the hTDGN(111–410)
and hTDG-core(111–308) activity (data not shown).
Figure 2. Determination of regions within hTDG involved in
binding to the 9-1-1 components. (A and B) Interactions of His-
tagged hHus1 with GST-hTDG constructs. His-tagged hHus1 (100ng)
expressed in E. coli was incubated with GST-TDG constructs or
GST alone immobilized on beads. The pellets were fractionated on a
12% SDS–PAGE followed by western blot analysis with the His
antibody. Lane 1 contains 10ng His-hHus1 (10% of the total input).
(C and D). Binding of the hTDGC1 and hTDG(67–308) deletion
mutants, respectively, to GST-hRad9, GST-hRad1 and GST-Hus1.
Immobilized GST-hHus1 (lane 2), GST-hRad1 (lane 3), GST-hRad9
(lane 4) and GST alone (lane 5) were incubated with 100ng each of
the constructs. Lane 1 of (C)o r( D) contains 10ng hTDGC1 or
hTDG(67–308), respectively.
Figure 3. Graphic depiction of hTDG constructs and the summary of physical and functional interactions of these constructs with the 9-1-1 complex.
The intact hTDG contains 410 amino acid residues. Deletion constructs are marked with the residue’s numbers at their N- and C-termini.
Stripped boxes are for His-tag, gray boxes are for the N-terminal domain, black boxes are for the core domain, and white boxes are for the
C-terminal domain. Point mutations are marked with stars. The physical interactions of hTDG and the 9-1-1 complex are derived from results of
Figures 1, 2 and 7 as well as data not shown. The functional interactions of hTDG and hHus1 are derived from results of Figures 4, 5 and 7 as well
as data not shown. ‘+’ for positive, ‘–’ for negative and ‘#’ for reduced interactions with either hHus1 or the 9-1-1 complex. ND represents no
enzyme activity.
Nucleic Acids Research, 2007, Vol. 35, No. 18 6211Thus, the functional interaction between the 9-1-1
complex and hTDG is parallel to their physical
interaction.
Computational analysis reveals that residues 67–110 of
hTDG are highly conserved among other vertebrate TDG
proteins (Figure 6). We have shown that V315 of hMYH
(marked with a star in Figure 6) and I261 of SpMYH are
important for their interactions with Hus1 (36). V315 of
hMYH is conserved with mammalian TDG proteins
(Figure 6). We thus constructed the hTDG(V74A)
mutant. hTDG(V74A) protein did not associate with the
GST-hHus1 immobilized on beads (Figure 7A). In the
reciprocal pull-down assay, the interaction between hHus1
and GST-hTDG(V74A) mutant was much reduced as
compared with wild-type hTDG immobilized on beads
(Figure 7B). The puriﬁed hTDG(V74A) mutant protein
Figure 4. Human TDG glycosylase activity can be stimulated by hHus1, hRad1, hRad9 and the 9-1-1 complex. (A) Human Hus1 expressed in
bacteria enhances the activities of TDG. Lane 1, T/G-containing DNA substrate. Lane 2, 1.8 fmol (0.18nM) of DNA substrate was incubated with
hTDG (0.1 nM). Lanes 3–8 are similar to lane 2 but with added 1.563, 3.13, 6.25, 12.5, 25 and 50nM hHus1, respectively. Lane 9, DNA was
incubated with 50nM hHus1. The products were separated on a 14% DNA sequencing gel. Arrows mark the intact DNA substrate (I) and the
cleavage product (N) after NaOH treatment. (B) hTDG glycosylase activity is enhanced by human (h9-1-1) complex. Reaction conditions are similar
to (A) except that lanes 3–7 contained 0.313, 0.625, 1.25, 2.5 and 5 nM human 9-1-1 complex expressed in the baculovirus-transfected insect cells,
respectively. Lane 8, DNA was incubated with 5 nM human 9-1-1 complex. (C) hTDG glycosylase activity is enhanced by S. pombe (Sp9-1-1)
complex. Reaction conditions are similar to (A) except that lanes 3–8 contained 0.313, 0.625, 1.25, 2.5, 5 and 10nM S. pombe 9-1-1 complex,
respectively. Lane 9, DNA was incubated with 10 nM S. pombe 9-1-1 complex. (D–F). Quantitative analyses of the fold of stimulation of hHus1,
human 9-1-1, S. pombe 9-1-1, respectively, on hTDG glycosylase activity from three experiments. In the presence of 0.1 nM hTDG-full,  1% of
DNA was cleaved. The error bars reported are the SD of the averages. (G) hTDG activity was stimulated by hHus1, hRad1 and hRad9 expressed in
the baculovirus-transfected insect cells. Lanes 1, 8 and 15, 1.8 fmol (0.18nM) of T/G-containing DNA substrate was incubated with hTDG (0.3nM).
Lanes 2–6 are similar to lane 1 but with added 3.13, 6.25, 12.5, 25 and 50nM hHus1, respectively. Lanes 9–13 are similar to lane 8 but with added
3.13, 6.25, 12.5, 25 and 50nM hRad1. Lanes 16–20 are similar to lane 15 but with added 3.13, 6.25, 12.5, 25 and 50nM hRad9, respectively. Lanes 7,
14 and 21, DNA substrate was incubated with 50 nM of hHus1, hRad1 and hRad9, respectively. (H) Quantitative analyses of the fold of stimulation
of hRad9 (diamonds), hRad1 (squares) and hHus1 (triangles) on hTDG glycosylase activity from three experiments. In the presence of 0.3 nM
hTDG-full,  12% of DNA was cleaved.
6212 Nucleic Acids Research, 2007, Vol. 35, No. 18was shown to exhibit similar glycosylase activity as the
wild-type enzyme (compare Figure 7C, lane 1 with
Figure 5A, lane 2). Consistent with its reduced physical
interaction with hHus1 (Figure 7A and B), hTDG(V74A)
required greater amounts of hHus1 for stimulation
(Figure 7C, lanes 2–6 and Figure 7D, diamonds). As a
control, the hTDG(V44A) interacted with hHus1 similarly
as the wild-type hTDG (data not shown). Therefore,
V74A of hTDG plays an important role in hHus1
interaction.
hTDG(67–308) has fullcatalytic activity
It has been reported that the eﬃcient hydrolysis of
thymines from T/G mismatches requires the N-terminal
sequence (9,12). Therefore, we determine whether
hTDG(67–308) can eﬃciently excise T from a T/G
mismatch by comparison with hTDG-full and hTDG-
core. Like many DNA glycosylases, TDG exhibits
essentially no enzymatic turnover due to strong binding
to its product (49). Thus, we measure the rate constant of
hTDG with both U/G- and T/G-containing DNA under
single turnover kinetics and saturating enzyme conditions
in which the concentration of hTDG is 10-fold excess
over DNA concentration under the exact condition of
Bennett et al. (8) by the HPLC method. hTDG(67–308)
had 21-fold higher rate for U/G-containing DNA than
T/G-containing substrate (Table 1). hTDG(67–308)
Figure 5. Human Hus1 can stimulate hTDG-N55, hTDGC and
hTDG(67–308) activities. (A) The stimulation eﬀect of hHus1 expressed
in bacteria on the glycosylase activities of TDG, hTDG-N55 and
hTDGC1. Lane 1, T/G-containing DNA substrate. Lane 2, 1.8 fmol
(0.18nM) of DNA substrate was incubated with hTDG (0.1nM).
Lanes 3–7 are similar to lane 2 but with added 1.563, 3.125, 6.25, 12.5
and 25nM hHus1, respectively. Lanes 8–13 are similar to lanes 2–7
except using hTDG-N55. Lanes 14–19 are similar to lanes 2–7 except
using hTDG-C1. The products were separated on a 14% DNA
sequencing gel. Arrows mark the intact DNA substrate (I) and the
cleavage product (N) after NaOH treatment. (B) Human Hus1 can
stimulate hTDG(67–308) activity. Lane 1, 1.8 fmol (0.18nM) of DNA
substrate was incubated with hTDG(67–308) (0.1nM). Lanes 2–6 are
similar to lane 1 but with added 1.563, 3.125, 6.25, 12.5 and 25 nM
hHus1, respectively. (C) Quantitative analyses of the fold of stimulation
of hHus1 on the glycosylase activity of hTDG(67–308) from three
experiments. In the presence of 0.1 nM hTDG(67–308),  4% of DNA
was cleaved.
Figure 6. Alignment of the Hus1 interacting domains on vertebrate
TDGs and hMYH. Sequences are: Homo sapiens TDG (hTDG, accession
No. AAI04478), mouse Mus musculus TDG (mTDG, accession
No. NP_766140), rat Rattus norvegicus TDG (rTDG, accession No.
AAI29089), chicken Gallus gallus TDG (chTDG, accession
No. NP_990081), frog Xenopus laevis TDG (xTDG, accession No.
AAH77465) and Homo sapiens MYH (hMYH, accession No. U63329).
A star marks V74 of hTDG and V315 of hMYH (36), which are
important for hHus1 binding. Identical amino acid residues are shaded
in black and conserved residues are boxed in gray.
Figure 7. Val74 of hTDG is important for interaction with hHus1.
(A) Binding of the hTDG wild-type (WT) and hTDG(V74A) mutant to
GST-hHus1. Immobilized GST-hHus1 (lanes 2 and 5) and GST alone
(lanes 3 and 6) were incubated with 100ng of hTDG wild-type (lanes 2
and 3) and hTDG(V74A) (lanes 5 and 6) proteins. The pellets were
fractionated by a 12% SDS–PAGE followed by western blot analysis
with the hTDG antibody. Lanes 1 and 4 contain 10ng (10% of the
total input) of hTDG-WT and hTDG(V74A), respectively.
(B) Interactions of His-tagged hHus1 with GST-hTDG (WT) and
GST-hTDG(V74A). His-tagged hHus1 (100ng) was incubated with
GST-TDG constructs or GST alone immobilized on beads. The pellets
were fractionated on a 12% SDS–PAGE followed by western blot
analysis with the His antibody. (C) The stimulation eﬀect of hHus1
expressed in bacteria on the glycosylase activities of hTDG(V76A).
The experiment was performed similarly as Figure 4A except using
hTDG(V74A). Lane 1, 1.8 fmol (0.18nM) of DNA substrate was
incubated with hTDG(V74A) (0.1nM). Lanes 2–6 are similar to lane 1
but with added 1.563, 3.125, 6.25, 12.5 and 25nM hHus1, respectively.
(D) Quantitative analyses of the fold of stimulation of hHus1 on
the glycosylase activity of hTDG-WT (circles) and hTDG(V74A)
(diamonds) from two experiments.
Nucleic Acids Research, 2007, Vol. 35, No. 18 6213removes U from U/G mispairs with a rate of kmax =
2.15min
 1, similar to that of intact hTDG (Table 1). The
activity of hTDG(67–308) against T/G mispairs is 2-fold
slower than that of intact TDG (0.104min
 1 versus
0.19min
 1, Table 1). In contrast, the smaller hTDG-core
(111–308) has lower activity than hTDG-full, 3.4-fold
lower for U/G and 15-fold lower for T/G mispairs
(Table 1). Thus, residues 67–110 are necessary for
full catalytic activity. In contrast to previous reports
(9,12), the core domain TDG(111–308) has signiﬁcant
activity on T/G mispairs with kmax=0.013min
 1. These
observations indicate that hTDG(67–308) acts like intact
enzyme.
DNA damage stimulates theinteraction ofhTDG–hRad9
To investigate the eﬀect of DNA damage on the
interaction between hTDG and the 9-1-1 complex, we
performed Co-IP experiments with extracts from MNNG-
treated HeLa cells. In these experiments, hTDG could be
immunoprecipitated by hRad9 antibody from HeLa
extracts (Figure 1B, lane 2). Interestingly, the interaction
between hRad9 and hTDG was enhanced after MNNG
treatment (Figure 1B, lanes 3 and 4). This result indicates
that hTDG–hRad9 interaction is enhanced following
treatment with a DNA methylation agent.
Co-localization between hTDG and the9-1-1 complex
Next, we tested whether hTDG and hRad9 translocated to
the same nuclear foci following DNA damage. Using an
indirect immunoﬂuorescent method, we showed that
hRad9 foci were co-localized to some of hTDG foci
after MNNG and TMZ treatments (Figure 8). Several
large yellow foci were observed in MNNG-treated
cells (Figure 8H). In TMZ-treated cells, hTDG and
hRad9 formed discrete nuclear foci (Figure 8J and K).
A signiﬁcant fraction of the hTDG nuclear foci were
found to co-localize with hRad9 foci in TMZ-treated
cells (Figure 8L). This data indicates that hTDG and
the 9-1-1 complex accumulate in repair foci following
DNA damage.
DISCUSSION
It has been suggested that the BER pathway involves
highly coordinated processes governed by protein–protein
and protein–DNA interactions (50–53). In this study, we
show that hTDG interacts with hRad9, hRad1 and hHus1
as individual proteins and as a complex. The glycosylase
activity of hTDG is stimulated by hHus1, hRad1, hRad9,
separately and the 9-1-1 complex. Because the functional
interaction is parallel with the physical interaction
between hTDG and the 9-1-1 complex, the 9-1-1 complex
may stimulate hTDG by a direct contact with hTDG.
Recently, the 9-1-1 complex has been shown to interact
with and stimulate the enzymes involved in BER including
MYH (35,36), NEIL1 (37), APE1 (38), Polb (39),
FEN1 (40,41) and DNA ligase l (42,43). Thus, the 9-1-1
complex is not only a DNA damage sensor (27) but is
also involved in the BER pathway. The 9-1-1 complex
stimulates the activities of APE1 and ligase 1 without
encircling the DNA (38,43). This is consistent with our
ﬁnding that individual subunits of the 9-1-1 complex can
stimulate the glycosylase activities of TDG (this study),
MYH (36) and NEIL1 (37). However, the 9-1-1 complex
may function more eﬃciently than individual subunits
(Figure 4).
We have shown that the 9-1-1 complex physically and
functionally interacts with hNEIL1 (37) and MYH in
S. pombe and human cells (35,36). Human TDG is the
third glycosylase to interact with the 9-1-1 complex.
Unlike MYH that interacts with the 9-1-1 complex
mainly via the Hus1 subunit (35,36), hTDG and
hNEIL1 interact with hHus1, hRad1 and hRad9 equally.
Because these three glycosylase have distinct substrate
speciﬁcities, the 9-1-1 complex needs to be channeled to
diﬀerent BER pathways in response to diﬀerent DNA
damage signals. Both hMYH and hNEIL1 co-localize
with hRad9 following H2O2 treatment and hTDG
co-localizes with hRad9 following treatments with methyl-
ating agents.
Table 1. The rate constantsof hTDG contructs with DNA substrates
containing an U/G mismatch or T/G mismatch
Construct U/G DNA T/G DNA
Kmax(min
 1) Kmax (min
 1)
hTDG-full 2.70 0.15
a 0.19 0.04
a
hTDG(67-308) 2.15 0.01 0.104 0.008
hTDG-core 0.80 0.20 0.013 0.001
aRate constants in this study are comparable to those derived from
Bennett et al. (8).
Figure 8. Co-localization of hTDG and hRad9 in HeLa cells following
MNNG and TMZ treatments. (A–D). Control cells without treatment.
(E–H). Cells were treated with 0.4mMo fN-methyl-N0-nitro-
N-nitrosoguanidine (MNNG) for 24h. (I–L). Cells were treated with
40mM of TMZ for 24h. (A), (E) and (I), DAPI stain; (B), (F) and (J),
immunoﬂuorescent staining with antibody against hTDG; (C), (G) and
(K), immunoﬂuorescent staining with antibody against hRad9; (D),
merge of (B) and (C); (H), merge of (F) and (G) and (L), merge of (J)
and (K). Co-localization of hTDG (green) and hRad9 (red) was
visualized as yellow. Human TDG and Rad9 antibodies used are from
Serotec and Imgenex, respectively.
6214 Nucleic Acids Research, 2007, Vol. 35, No. 18A consensus PCNA-binding motif [QXX(L/V)XXF
(F/Y)] is found in many proteins involved in DNA
replication, DNA repair, DNA methylation and chroma-
tin assembly (54,55). Recently the list of proteins that
interact with 9-1-1 has been expanding; however, the
consensus-binding motif to the 9-1-1 complex is not clear.
Our mapping analyses indicate that the 9-1-1 complex
interacting domain is localized to residues 67–110 of
hTDG and Val74 of hTDG plays an important role in
TDG–Hus1 interaction. A comparison of the hHus1
interacting domains of hTDG and hMYH reveals
several conserved amino acids including a conserved
Val (marked with a star in Figure 6). It is signiﬁcant
that both V74 of hTDG and V315 of hMYH (36) play
important roles in term of their respective interactions
with hHus1. Thus, the interactions between DNA
glycosylases and the 9-1-1 complex appear to involve
hydrophobic interactions. However, this conserved Val is
not present in chicken and Xenopus TDG sequences
(Figure 6). Thus, the protein networks in TDG-directed
BER may vary among diﬀerent organisms. The crystal
structure of a catalytic core of TDG (residues 112–339)
conjugated to SUMO lacks residues 67–111 (15,16). Our
preliminary NMR data (Fitzgerald,M., Lu,A.-L. and
Drohat,A.C., unpublished data) indicate that a signiﬁcant
portion of hTDG(56–308) is disordered while hTDG-core
(110–308) is well structured. This indicates that the
N-terminal domain (residues 56–110) is unstructured.
The Hus1 interacting domain of hNEIL1 (residues
290–350) may also be ﬂexible because no identiﬁable
density beyond residues 290 can be detected in the crystal
structure of hNEIL1 containing residues 2–342 (56).
The Hus1 interacting domain of hMYH (residues
295–350) is not present in the bacterial MutY structure
(57,58). Based on both secondary structure (59) and
disorder prediction (60), the region containing residues
295–350 of hMYH is also likely unstructured. Thus, a
common feature of the Hus1-binding motif appears to
have a disorder structure in solution. It is possible that this
region becomes structured in the presence of the 9-1-1
complex and then this conformational change promotes
the catalytic activities of DNA glycosylases. We have
shown here that this disordered region (residues 67–110)
of hTDG contributes to greater catalytic activity as
compared to the core domain (residues 110–308)
(Table 1). It is interesting to note that Hus1 interacting
regions of hTDG and hMYH overlap with their
APE1 interacting domains (17,45). It has been pointed
out that many disordered segments fold on bind-
ing to their biological targets and permit protein
promiscuity (61).
Mammalian cell cycle checkpoints have been recognized
as key tumor-suppressor mediators that prevent the
accumulation of mutations, which promote carcinogenesis
(62,63). Checkpoints also fulﬁll a broad range of
additional functions in development. It has been shown
that targeted deletion of many murine checkpoint genes,
including Atr (64), Chk1 (65,66), Hus1 (67), Rad9 (68)
and Rad17 (69), resulted in embryonic lethality. It is
interesting to note that Tdg
 /  knockout mice are also
embryonically lethal (23). Although TDG plays other
roles beside DNA repair, its role in DNA damage
response may be related to the embryonic lethality of
Tdg
 /  knockout mice (23).
Methylating agents are widely used as anticancer drugs.
For example, TMZ has been used as a chemotherapy
agent for brain tumor (70). Although both MNNG and
TMZ are methylating agents, the distribution patterns of
the foci of hTDG and hRad9 are diﬀerent when cells are
treated with these agents (Figure 8). The reason is
not clear. The biological eﬀects of methylation agents,
such as cell cycle arrest and apoptosis, are mostly linked to
O
6-methylguanine (MeG), which can also be formed by
tobacco smoke and methylnitrosourea. The MeG lesions
can be repaired in a saturable manner by the suicide
enzyme MeG methyltransferase (MGMT) (71). However,
MGMT is inactivated in most solid tumor cells, and the
persistence of MeG causes cytotoxicity. In vivo mutagen-
esis assays have shown that MeG mispairs with T during
replication to give mutagenic T/MeG mispairs (72,73).
Mismatch repair (MMR) enzymes MSH2/MSH6, TDG
and MBD4 can recognize or excise T from T/MeG
mispairs (74–78), and have an eﬀect on the toxicity of
methylating agents. MMR-deﬁcient and MBD4-deﬁcient
cells have been shown to be resistant (or tolerant) to
methylating agents (74,75,77). Given the ability of TDG
to act on T/MeG (76,78), TDG may aﬀect the cytotoxicity
of methylating agents. Two models have been proposed
to address the cytotoxicity of MeG: (i) a direct recognition
of T/MeG mispairs by repair proteins initiates the
signaling pathway leading to apoptosis and (ii) the
repair enzymes remove the mispaired T on the daughter
strand, but the persistence of MeG on the parental strand
promotes futile cycles of excision and resynthesis, which
ultimately result in apoptosis. The interaction between
TDG and the 9-1-1 complex may play a role in this
signaling pathway.
The 9-1-1 complex, Rad17 and ATM/ATR are pro-
posed to act at an early step to sense DNA damage
(27,79). There are two models to address how these
sensors are recruited to the damaged sites. In the ﬁrst
model, these checkpoint proteins may detect a common
intermediate, such as single-stranded DNA coated by
replication protein A (RPA), which is processed by
various DNA repair pathways (28). RPA has been
shown to directly interact with the 9-1-1 complex (80).
In the second model, these checkpoint proteins may
require a series of ‘adaptors’ to recognize DNA damage.
Such adaptor proteins may be DNA damage recognition
proteins involved in BER, mismatch repair, nucleotide
excision repair and double-strand break repair (81–85).
Our ﬁndings that three DNA glycosylases interacts with
the 9-1-1 complex support the model that checkpoint
proteins require a series of ‘adaptors’ to recognize DNA
damage. In this model, a DNA glycosylase ﬁrst recognizes
speciﬁc DNA lesions, and then recruits Rad9–Rad1–Hus1
to stimulate BER and to initiate the signal response
pathway.
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